180 related articles for article (PubMed ID: 32790092)
1. Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131.
Velu P; Vijayalakshmi A; Vinothkumar V
J Pharm Pharmacol; 2020 Nov; 72(11):1595-1606. PubMed ID: 32790092
[TBL] [Abstract][Full Text] [Related]
2. Betanin alleviates inflammation and ameliorates apoptosis on human oral squamous cancer cells SCC131 and SCC4 through the NF-κB/PI3K/Akt signaling pathway.
Zou X; Yu K; Chu X; Yang L
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23094. PubMed ID: 35645143
[TBL] [Abstract][Full Text] [Related]
3. Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells.
Tanagala KKK; Baba AB; Kowshik J; Reddy GB; Nagini S
Anticancer Agents Med Chem; 2018; 18(14):2042-2052. PubMed ID: 30062975
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells.
Aggarwal S; John S; Sapra L; Sharma SC; Das SN
Cancer Chemother Pharmacol; 2019 Mar; 83(3):451-461. PubMed ID: 30519710
[TBL] [Abstract][Full Text] [Related]
5. Akt Signal Transduction Pathways and Nuclear Factor-kappa B (NF-κB) Transcription as a Molecular Target of Oral Tongue Squamous Cell Carcinoma (SP-C1) Using Papua's Anthill Plant ( Myrmecodia pendans ).
Achmad H; Supriatno ; Singgih MF; Hendrastuti H
Pak J Biol Sci; 2016; 19(8-9):323-330. PubMed ID: 29023018
[TBL] [Abstract][Full Text] [Related]
6. Syringic acid suppresses oral squamous cell carcinoma SCC131 cell proliferation via modulation of mitochondria-mediated apoptosis signaling pathways.
Velu P; Vijayalakshmi A; Vinothkumar V
J Biochem Mol Toxicol; 2020 Dec; 34(12):e22586. PubMed ID: 32711406
[TBL] [Abstract][Full Text] [Related]
7. Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models.
Kowshik J; Nivetha R; Ranjani S; Venkatesan P; Selvamuthukumar S; Veeravarmal V; Nagini S
IUBMB Life; 2019 Oct; 71(10):1595-1610. PubMed ID: 31251469
[TBL] [Abstract][Full Text] [Related]
8. Membrane-tethered Notch1 exhibits oncogenic property via activation of EGFR-PI3K-AKT pathway in oral squamous cell carcinoma.
Zheng Y; Wang Z; Xiong X; Zhong Y; Zhang W; Dong Y; Li J; Zhu Z; Zhang W; Wu H; Gu W; Wu Y; Wang X; Song X
J Cell Physiol; 2019 May; 234(5):5940-5952. PubMed ID: 30515785
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
10. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
11. Syringic acid regulates suppression of the STAT3/JNK/AKT pathway via inhibition of human ovarian teratoma cancer cell (PA-1) growth-in vitro study.
Yang L; Qu C; Jin J; Yang H; Pei L
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-9. PubMed ID: 33759321
[TBL] [Abstract][Full Text] [Related]
12. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
He W; Lai R; Lin Q; Huang Y; Wang L
J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
[TBL] [Abstract][Full Text] [Related]
13. The extract of Curcumae Longae Rhizoma suppresses angiogenesis via VEGF-induced PI3K/Akt-eNOS-NO pathway.
Guo GX; Wu KY; Zhang XY; Lai FX; Tsim KW; Qin QW; Hu WH
J Ethnopharmacol; 2023 May; 308():116299. PubMed ID: 36842721
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
15. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
16. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma.
Shibuya CM; Tjioe KC; Oliveira SHP; Bernabé DG
Arch Oral Biol; 2022 Apr; 136():105383. PubMed ID: 35240444
[TBL] [Abstract][Full Text] [Related]
17. Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling.
Cui H; Yuan J; Du X; Wang M; Yue L; Liu J
Oncol Rep; 2015 Mar; 33(3):1284-90. PubMed ID: 25522911
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
[TBL] [Abstract][Full Text] [Related]
19. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9.
Kuo CL; Lai KC; Ma YS; Weng SW; Lin JP; Chung JG
Oncol Rep; 2014 Jul; 32(1):355-61. PubMed ID: 24859325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
